Welcome to Tech Beat, your morning briefing on the stories shaping the technology landscape.
In biotech, Ultragenyx is cutting staff following another failed clinical study, a painful reminder of how brutal drug development can be. Meanwhile, Novo Nordisk is upgrading its annual guidance, driven by stronger than expected performance from the Wegovy pill, even as competition in the weight loss drug space continues to intensify.
Shifting to cybersecurity, researchers have disclosed a serious vulnerability in Barracuda's Email Security Gateway appliances. An authentication bypass flaw can be chained with a command injection exploit to grant attackers full root access. If your organization runs one of these devices, patching should be at the top of your list today, not tomorrow.
And on the crypto policy front, the Blockchain Association is pushing the incoming Congress to finish what previous sessions started — building a clear regulatory framework for digital assets. The argument is familiar: protect consumers without strangling innovation. What's different now is the political window may finally be open to get something done.
That's your morning tech briefing. Keep surfing. Tech Beat out.
